Pay in 4 interest-free payments of $5.98 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Other conditions include arrhythmia (abnormal heart rhythms), congenital heart failure, and heart valve problems
A core highlight includes the Phase 3 ACHIEVE trial results for Foundayo, an oral small-molecule GLP-1 receptor agonist taken without food or water restrictions
Isocitrate Dehydrogenases (IDH) Humans express three different IDH enzymes identified as IDH1, IDH2, and IDH3
KFF data showed two-thirds of state Medicaid programs said cost was a decision factor when determining coverage of GLP-1 drugs
US$ 20.55
US$ 20.95
US$ 25.03
US$ 24.73
